A travel ban and an old vaccine. The Trump administration is banning foreign travelers from entering the U.S. if they’ve been ...
Agilent Technologies (A) is back in focus after receiving U.S. FDA approval for its PD-L1 IHC 22C3 pharmDx assay as a companion diagnostic for esophageal and gastroesophageal junction carcinoma ...
Kennedy touts MAHA. This Mother's Day, note what his misinformation and policies really do to moms: reduce access to care, ...
Jell-O is getting a line of products made without synthetic colors or artificial sweeteners to meet increasing consumer ...
The main appeal still lies with sabirnetug, which could offer meaningful upside if Phase 2 data supports a viable path into ...
Neuren Pharmaceuticals (ASX:NEU) and its US partner Acadia Pharmaceuticals have been blitzing it with its Rett syndrome drug ...
NDA Submission Status -- D-PLEX100 rolling New Drug Application was initiated with the FDA on March 30, 2026, with CMC, nonclinical, and administrative modules submitted, and the clinical module ...
PolyPid Ltd. (NASDAQ: PYPD) Q1 2026 Earnings Call Transcript May 13, 2026 PolyPid Ltd. beats earnings expectations. Reported ...
The real danger exposed by Chinese agricultural espionage is the fragility created by patented genetically engineered ...
I tried RHA lip filler after regretting my first filler experience. Here’s my honest review, including before-and-after ...
We gave Trump two chances to repair it, New Yorkers are testing Mayor Zohran Mamdani’s resolve and now Mainers are poised to do the same with Platner. Democrats have the opportunity to embrace an ...
The first time I got lip filler, I went in mostly blind. Sure, I’d seen videos on YouTube and gone down various rabbit holes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results